NFE2L2 and neoplasm: Crucially, we established a T cell-specific overexpression animal model, demonstrating that Nrf2 overexpression dampens the anti-tumor response, whereas, conversely, Nrf2−/− promotes T cell-driven anti-tumor responses across multiple in vivo models.